These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8834885)

  • 1. Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers.
    Oethinger M; Conrad S; Kaifel K; Cometta A; Bille J; Klotz G; Glauser MP; Marre R; Kern WV
    Antimicrob Agents Chemother; 1996 Feb; 40(2):387-92. PubMed ID: 8834885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysis.
    Oethinger M; Jellen-Ritter AS; Conrad S; Marre R; Kern WV
    Infection; 1998; 26(6):379-84. PubMed ID: 9861564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
    Kern WV; Klose K; Jellen-Ritter AS; Oethinger M; Bohnert J; Kern P; Reuter S; von Baum H; Marre R
    Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):111-8. PubMed ID: 15714332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.
    Kern WV; Andriof E; Oethinger M; Kern P; Hacker J; Marre R
    Antimicrob Agents Chemother; 1994 Apr; 38(4):681-7. PubMed ID: 8031031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of fluoroquinolone-resistant Escherichia coli causing septicemic colibacillosis in calves in Italy: emergence of a multiresistant O78 clonal group.
    Marchese A; Coppo E; Barbieri R; Zoppi S; Pruzzo C; Rossi F; Bergagna S; Dondo A; Debbia E
    Microb Drug Resist; 2012 Feb; 18(1):94-9. PubMed ID: 22022869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
    Conrad S; Oethinger M; Kaifel K; Klotz G; Marre R; Kern WV
    J Antimicrob Chemother; 1996 Sep; 38(3):443-55. PubMed ID: 8889719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea.
    Cheong HJ; Yoo CW; Sohn JW; Kim WJ; Kim MJ; Park SC
    Clin Infect Dis; 2001 Jul; 33(1):48-53. PubMed ID: 11389494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status.
    Johnson JR; Kuskowski MA; Menard M; Gajewski A; Xercavins M; Garau J
    J Infect Dis; 2006 Jul; 194(1):71-8. PubMed ID: 16741884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia.
    Platell JL; Cobbold RN; Johnson JR; Trott DJ
    J Antimicrob Chemother; 2010 Sep; 65(9):1936-8. PubMed ID: 20570998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates.
    Usein CR; Tatu-Chiţoiu D; Nica M; Ciontea SA; Palade AM; Condei M; Damian M
    Roum Arch Microbiol Immunol; 2008; 67(1-2):23-9. PubMed ID: 19284163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular epidemiology of quinolone-resistant Escherichia coli isolated from urinary tract infection.
    Eom JS; Hwang BY; Sohn JW; Kim WJ; Kim MJ; Park SC; Cheong HJ
    Microb Drug Resist; 2002; 8(3):227-34. PubMed ID: 12363013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
    Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans.
    Johnson JR; Kuskowski MA; Owens K; Gajewski A; Winokur PL
    J Infect Dis; 2003 Sep; 188(5):759-68. PubMed ID: 12934193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging fluoroquinolone-resistance for common clinically important gram-negative bacteria in Taiwan.
    Sheng WH; Chen YC; Wang JT; Chang SC; Luh KT; Hsieh WC
    Diagn Microbiol Infect Dis; 2002 Jun; 43(2):141-7. PubMed ID: 12088622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
    Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
    Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.
    Puig C; Tirado-Vélez JM; Calatayud L; Tubau F; Garmendia J; Ardanuy C; Marti S; de la Campa AG; Liñares J
    Antimicrob Agents Chemother; 2015 Jan; 59(1):461-6. PubMed ID: 25385097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.